CONDENSED COMBINED AND CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 132,482	$ 188,498
Restricted cash	1,259	2,662
Accounts receivable, less allowance of $151 and $32 as of June 30, 2022 and December 31, 2021, respectively	2,702	553
Unbilled receivables	1,475	91
Inventory	4,002	4,310
Prepaid expenses and other current assets	1,796	1,357
Due from related parties		14
Total current assets	143,716	197,485
Property and equipment, net	3,448	3,753
Other long term assets	1,167	1,235
Total assets	148,331	202,473
CURRENT LIABILITIES:
Accounts payable	741	2,248
Deferred grant funding	1,259	2,662
Deferred revenue	1,449	730
Due to related parties	61	1,981
Accrued expenses and other current liabilities	8,949	8,115
Total current liabilities	12,459	15,736
Long term deferred revenue	889	510
Total liabilities	13,348	16,246
COMMITMENTS AND CONTINGENCIES (NOTE 12)
STOCKHOLDERS' EQUITY:
Additional paid-in capital	331,401	322,540
Accumulated deficit	(196,425)	(136,320)
Total stockholders' equity	134,983	186,227
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	148,331	202,473
Class A Common Stock
STOCKHOLDERS' EQUITY:
Common stock	5	5
Class B Common Stock
STOCKHOLDERS' EQUITY:
Common stock	$ 2	$ 2